A carregar...
Evaluation of Vancomycin Dosing in Pediatric Cystic Fibrosis Patients
OBJECTIVES: The presence of methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis (CF) patients' sputa is associated with a decline in pulmonary function and increased mortality. Vancomycin is the preferred treatment for MRSA pneumonia in children. No published studies have eval...
Na minha lista:
| Publicado no: | J Pediatr Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pediatric Pharmacy Advocacy Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4869773/ https://ncbi.nlm.nih.gov/pubmed/27199623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-21.2.155 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|